A major UK Biobank study shows that inconsistent sleep timing, not just sleep duration, is associated with increased risk for 172 diseases, including liver cirrhosis and cardiovascular conditions.
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
The need for public health officials to be able to model the spread of an infectious disease has never been more apparent than in the early days of the SARS-CoV-2 pandemic.
Investigators from Brigham and Women's Hospital, have unveiled a pivotal connection between genetic changes in microglia, immune-regulating brain cells, and the inflammatory response associated with Alzheimer's disease (AD).
Michael Wong and Amy Campbell from the Physician-Patient Alliance for Health & Safety reflect on the fourth World Sepsis Congress discussion, which focused on ways to improve long-term health outcomes post sepsis.
A group of researchers around the globe have created a portable, non-invasive device capable of identifying biomarkers associated with Alzheimer's and Parkinson's disease.
Dr Tracey Pollard from RNID, the charity which supports the 12 million people in the UK who are deaf, have hearing loss or tinnitus, talks us through the causes and impact of hearing loss and how RNID is working to improve research and related treatments in this field.
Gillian Molloy, Director of Market Access at AscellaHealth, examines the rare disease landscape in the UK, including progress in improving patient care and challenges in diagnostics and the development of new treatments.
A new policy brief from the European Observatory created with and for the Swedish Presidency of the Council of the EU details concrete steps for urgent action on AMR.
Polycystic kidney disease is a genetic disorder that lacks a cure and can significantly impact an individual’s quality of life. We spoke to the American Kidney Fund regarding the challenges of diagnosis and disease management.
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
Research conducted by the University of Surrey suggests that insulin icodec, a weekly basal injection, may be just as effective when treating type 1 diabetes compared to daily basal insulin treatments.
A study has revealed that a 1 % decrease in deep sleep each year among individuals aged 60 and older can lead to a 27 % rise in the risk of developing dementia.
UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
